Novartis Investigative Site

Grafton, Auckland

0 studies enrolling now · 2 studies all time

What they study most

Endometrial Cancer, Islet Cell Tumor, Second-line Treatment, Solid Tumors and Advanced Endometrial Cancer, VEGF

Studies at this site

• Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET — Stopped early
• A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer — Completed